Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF) A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

NCT01555320 is registered in ClinicalTrials.gov with State Administration of Traditional Chinese Medicine of the People's Republic of China as lead sponsor.

NCT NCT01555320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01555320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF) A Randomized, Double-blind, Multicenter, Placebo-controlled Trial
Lead sponsor
State Administration of Traditional Chinese Medicine of the People's Republic of China
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2012
Completion date
December 31, 2013
Enrollment
640 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart failure